This site is intended for Healthcare professionals only.
×

Sun Pharma raises Rs 1,000 cr via NCDs

Sun Pharma raises Rs 1,000 cr via NCDs

New Delhi: Drug major Sun Pharma Industries said it has raised Rs 1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis.

 

“Sun Pharma Laboratories Ltd, a wholly-owned subsidiary of the company, has raised, on private placement basis, Rs 1,000 crore by allotment of 10,000 unsecured redeemable non-convertible debentures of a face value of Rs 10,00,000 each,” Sun Pharmaceutical Industries said in a BSE filing.

 

It further said: “NCDs will be listed on BSE Ltd under two series with Series 1 debentures comprising 5,000 debentures amounting to Rs 500 crore with a tenor of 24 months, and Series 2 debentures comprising 5,000 debentures amounting to Rs 500 crore with a tenor of 39 months.”

The company did not elaborate on the usage of proceeds.

0 comment(s) on Sun Pharma raises Rs 1,000 cr via NCDs

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted
    Source: PTI

    Opinion Polls

    Should Government Doctors be allowed to do Private Practice?